CELH
Celsius Holdings, Inc.
CELH has the edge over USFD overall, supported by stronger fundamentals and stronger valuation.
USFD
US Foods Holding Corp.
USFD has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
USFD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
USFD's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over USFD in the historical PE scenario, which offers more potential upside but is not a forecast.
USFD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $87.14 | -20% |
| Current | 30x | $108 | — |
| Fair | 31x | $111 | +2.6% |
| Expensive | 40x | $145 | +34% |
Historical ranges are pointers, not guarantees.
USFD's PE is in its fair range at 30x.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
USFD Forward outlook
There aren't enough analyst estimates for USFD to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
USFD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.58 | +49% |
| Q2 2026 | $3.25 | +39% |
| Q1 2026 | $2.97 | +36% |
| Q4 2025 | $2.94 | +46% |
| Q3 2025 | $2.40 | +3% |
| Q2 2025 | $2.34 | +11% |
| Q1 2025 | $2.18 | +7.4% |
| Q4 2024 | $2.02 | 0% |
USFD has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over USFD on profitability, with a higher operating margin.
USFD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.4B | +2.1% |
| Q2 2026 | $10.5B | +4.5% |
| Q1 2026 | $9.6B | +2.8% |
| Q4 2025 | $9.8B | +3.3% |
| Q3 2025 | $10.2B | +4.8% |
| Q2 2025 | $10.1B | +3.8% |
| Q1 2025 | $9.4B | +4.5% |
| Q4 2024 | $9.5B | +6.2% |
USFD's revenue has grown year over year for 22 quarters in a row: $10.4B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.6% | +0.8 points |
| Q2 2026 | 4.2% | +0.5 points |
| Q1 2026 | 2.3% | -0.1 points |
| Q4 2025 | 3.3% | +0.1 points |
| Q3 2025 | 2.8% | -0.1 points |
| Q2 2025 | 3.7% | 0 points |
| Q1 2025 | 2.4% | +0.6 points |
| Q4 2024 | 3.2% | +0.1 points |
USFD's operating margin was 3.6% last quarter, up 0.8 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
USFD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $343M | +45% |
| Q2 2026 | $355M | +38% |
| Q1 2026 | $196M | -36% |
| Q4 2025 | $159M | -11% |
| Q3 2025 | $236M | +24% |
| Q2 2025 | $257M | -38% |
| Q1 2025 | $307M | +490% |
| Q4 2024 | $178M | +183% |
USFD has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
USFD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -3.3M shares |
| 1 year | -4.7% | -10.7M shares |
| 3 years | -13% | -31.3M shares |
| 5 years | -3.2% | -7.3M shares |
| Available history | -1% | -2.3M shares |
USFD has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $190M |
| Q2 2026 | $370M |
| Q1 2026 | $75M |
| Q4 2025 | $324M |
| Q3 2025 | $332M |
| Q2 2025 | $247M |
| Q1 2025 | $23M |
| Q4 2024 | $320M |
USFD spent $959M buying back its own shares over the past year, up 4% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over USFD on leverage, with a lower net debt burden relative to earnings.
USFD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.0x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.2x | Elevated |
USFD's net debt is about 2.8 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
USFD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.9 | Neutral |
| Stochastic | 72.5 | Neutral |
USFD's weekly RSI is 63 (neutral) and its Stochastic is 73 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
USFD PE vs Consumer Defensive Sector
| Metric | USFD | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 19x | 55% above |
| PE % | 45 | 18 | 27 pts above |
USFD has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
USFD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $101.1 | 7% above |
| 20 week MA | $101.8 | 6.3% above |
| 50 week MA | $93.0 | 16% above |
| 100 week MA | $83.0 | 30% above |
| 200 week MA | $65.4 | 65% above |
USFD has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
USFD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.8 | $33.3 | -20% |
| 2021 | $33.3 | $34.6 | +3.8% |
| 2022 | $34.6 | $34.7 | +0.3% |
| 2023 | $34.7 | $45.4 | +31% |
| 2024 | $45.4 | $68.2 | +50% |
| 2025 | $68.2 | $76.4 | +12% |
| 2026 YTD | $76.4 | $108.3 | +42% |
USFD has the edge over CELH on returns for 2026, with the stronger performance.